November 28, 2023

The Time is Now for Biosimilars

With the increasing release of biosimilars, listen to this discussion about their use, fear of change, dual pricing strategies, and who will see cost savings with Jason Harris, NPF Vice President of Government Relations and Advocacy, Dr. Colby Evans, dermatologist and past chair of the NPF Board, and Anna Hyde, Vice President of the Advocacy and Access Department at the Arthritis Foundation.

Jason Harris, VP of Government Relations and Advocacy, NPF; Dr. Colby Evans, Dermatologist, Past Board Chair, NPF; Anna Hyde, VP of Advocacy and Access, Arthritis Foundation.

This Psound Bytes™ episode is sponsored by Sandoz and Boehringer Ingelheim.    

Still Have Questions?

Find articles, webinars, resources, and more on biosimilars and how they may impact your treatment plan.

Learn more
Related Items

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2023 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.